Concepedia

Michael J. Keating

MJ

6

Publications

455

Citations

6

H-Index

1988

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Michael J. Keating is an author at The University of Texas MD Anderson Cancer Center specializing in hematology, pharmacotherapy, and medicine.

Top concepts

MedicineHematologyPharmacotherapyOncologyImmunologyPharmacologyCancer ResearchPathologyCell BiologyImmunotherapy

Publications per year

1988–2001

6

Publications

6

DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine.

Takahiro Yamauchi, Billie Nowak, Michael J. Keating et al. · PubMed · 2001 · 196 citations

Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia.

Varsha Gandhi, A. Kemena, Michael J. Keating et al. · PubMed · 1992 · 94 citations

Hematological Malignancy, Chronic Lymphocytic Leukemia, Medicine +12

Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

Hagop M. Kantarjian, Moshe Talpaz, Michael J. Keating et al. · Cancer · 1991 · 53 citations · Full text

Hematological Malignancy, Medicine, Intensive Chemotherapy Induction +13

Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia

Ronald S. Walters, Hagop M. Kantarjian, Michael J. Keating et al. · Cancer · 1988 · 51 citations

Hematological Malignancy, Salvage Chemotherapy, Medicine +12

Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia

Hagop M. Kantarjian, Ronald Walters, Michael J. Keating et al. · Cancer · 1990 · 51 citations · Full text

Rows per page

1–5 of 6